ROCKLAGE SCOTT M

CIK 000121901422 companiesMENLO PARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001219014

Recent Transactions

50 trades

Award
Aprea Therapeutics, Inc.$APRE
Stock Option (right to Buy)
2020-06-30+5,600→ 5,600 total
Sale
Aprea Therapeutics, Inc.$APRE
Common Stock
2020-06-16$33.30/sh−115,357→ 1,823,192 total
Sale
Aprea Therapeutics, Inc.$APRE
Common Stock
2020-06-16$33.30/sh−4,807→ 75,965 total
Sale
Aprea Therapeutics, Inc.$APRE
Common Stock
2020-06-11$28.75/sh−235,200→ 1,938,549 total
Sale
Aprea Therapeutics, Inc.$APRE
Common Stock
2020-06-11$28.75/sh−9,800→ 80,772 total
Sale
Aprea Therapeutics, Inc.$APRE
Common Stock
2020-05-19$35.15/sh−244,800→ 2,173,748 total
Sale
Aprea Therapeutics, Inc.$APRE
Common Stock
2020-05-19$35.15/sh−10,200→ 90,572 total
Conversion
Aprea Therapeutics, Inc.$APRE
Common Stock
2019-10-07+1,913,910→ 1,926,073 total
Conversion
Aprea Therapeutics, Inc.$APRE
Common Stock
2019-10-07+79,746→ 80,253 total
Conversion
Aprea Therapeutics, Inc.$APRE
Series B Convertible Preferred Stock
2019-10-07−79,746→ 0 total
Conversion
Aprea Therapeutics, Inc.$APRE
Series B Convertible Preferred Stock
2019-10-07−1,913,910→ 0 total
Conversion
Aprea Therapeutics, Inc.$APRE
Series C Convertible Preferred Stock
2019-10-07−492,475→ 0 total
Conversion
Aprea Therapeutics, Inc.$APRE
Series C Convertible Preferred Stock
2019-10-07−20,519→ 0 total
Conversion
Aprea Therapeutics, Inc.$APRE
Common Stock
2019-10-07+20,519→ 100,772 total
Conversion
Aprea Therapeutics, Inc.$APRE
Common Stock
2019-10-07+492,475→ 2,418,548 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2018-06-13+11,000→ 11,000 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2017-06-22+11,000→ 11,000 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2016-06-22+9,000→ 9,000 total
Award
Pulmatrix, Inc.$PULM
Stock Option (Right to Buy)
2016-02-03+8,800→ 8,800 total
Award
Pulmatrix, Inc.$PULM
Stock Option (Right to Buy)
2015-06-24+1,108→ 1,108 total
Award
Pulmatrix, Inc.$PULM
Stock Option (Right to Buy)
2015-06-16+17,710→ 17,710 total
Purchase
Pulmatrix, Inc.$PULM
Common Stock
2015-06-16$6.88/sh+4,815→ 168,873 total
Purchase
Pulmatrix, Inc.$PULM
Common Stock
2015-06-16$6.88/sh+33,990→ 1,192,154 total
Award
Pulmatrix, Inc.$PULM
Common Stock
2015-06-15+1,158,164→ 1,158,164 total
Award
Pulmatrix, Inc.$PULM
Common Stock
2015-06-15+164,058→ 164,058 total
Award
Pulmatrix, Inc.$PULM
Warrants to Purchase Common Stock
2015-06-15+52,784→ 52,784 total
Award
Pulmatrix, Inc.$PULM
Warrants to Purchase Common Stock
2015-06-15+372,606→ 372,606 total
Award
Pulmatrix, Inc.$PULM
Warrants to Purchase Common Stock
2015-06-15+52,784→ 52,784 total
Award
Pulmatrix, Inc.$PULM
Warrants to Purchase Common Stock
2015-06-15+372,606→ 372,606 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2015-06-09+9,000→ 9,000 total
Award
EPIRUS Biopharmaceuticals, Inc.
Non-Employee Stock Option (Right to Buy)
2015-06-05+9,000→ 9,000 total
Conversion
Cidara Therapeutics, Inc.$CDTX
Convertible Preferred Stock
2015-04-20−1,764,195→ 0 total
Conversion
Cidara Therapeutics, Inc.$CDTX
Convertible Preferred Stock
2015-04-20−45,467→ 0 total
Conversion
Cidara Therapeutics, Inc.$CDTX
Common Stock
2015-04-20+1,764,195→ 1,956,099 total
Conversion
Cidara Therapeutics, Inc.$CDTX
Common Stock
2015-04-20+45,467→ 50,412 total
Purchase
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2015-02-04$5.00/sh+10,050→ 65,699 total
Purchase
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2015-02-04$5.00/sh+389,950→ 2,549,211 total
Award
Achaogen, Inc.
Stock Option (Right to Buy)
2014-03-11+10,000→ 10,000 total
Exercise/Conversion
Relypsa Inc
Common Stock
2013-11-20$0.17/sh+102,036→ 2,056,334 total
Other
Relypsa Inc
Warrant to Purchase Preferred Stock
2013-11-20−102,036→ 0 total
Conversion
Relypsa Inc
Series C-2 Preferred Stock
2013-11-20−47,849→ 0 total
Other
Relypsa Inc
Warrant to Purchase Preferred Stock
2013-11-20−74,281→ 0 total
Other
Relypsa Inc
Warrant to Purchase Common Stock
2013-11-20+102,036→ 102,036 total
Conversion
Relypsa Inc
Common Stock
2013-11-20+207,347→ 2,131,294 total
Conversion
Relypsa Inc
Series C-2 Preferred Stock
2013-11-20−7,340→ 0 total
Tax Payment
Relypsa Inc
Common Stock
2013-11-20$11.00/sh−1,162→ 2,258,376 total
Exercise/Conversion
Relypsa Inc
Warrant to Purchase Common Stock
2013-11-20−442,160→ 0 total
Conversion
Relypsa Inc
Series A-1 Preferred Stock
2013-11-20−29,876→ 0 total
Other
Relypsa Inc
Warrant to Purchase Common Stock
2013-11-20+37,056→ 37,056 total
Other
Relypsa Inc
Warrant to Purchase Common Stock
2013-11-20+74,281→ 74,281 total

Recent Filings

Address

C/O 5AM VENTURES 2200 SAND HILL ROAD, SUITE 110

MENLO PARK, CA, 94025

View on SEC.gov